Related Experiment Videos
Liver-specific drug targeting by coupling to bile acids
1Hoechst Aktiengesellschaft, Frankfurt am Main, Federal Republic of Germany.
The Journal of Biological Chemistry
|September 15, 1992
Summary
Modified bile acids act as "Trojan horses" to deliver drugs specifically to the liver and biliary system. This research demonstrates a novel strategy for developing targeted liver therapies using bile acid-drug conjugates.
Area of Science:
- Pharmacology
- Hepatology
- Drug Delivery
Background:
- Bile acids are actively transported into hepatocytes via specific membrane transporters.
- Targeted drug delivery to the liver remains a significant challenge in pharmaceutical development.
Purpose of the Study:
- To investigate the potential of bile acids as carriers for targeted drug delivery to the liver.
- To synthesize and evaluate bile acid-drug conjugates for liver-specific transport and activity.
Main Methods:
- Covalent linkage of chlorambucil and a fluorescent peptide inhibitor to a bile acid derivative.
- Assessment of Na(+)-dependent taurocholate uptake inhibition in hepatocytes and vesicles.
- Evaluation of protein alkylation and biliary secretion profiles in liver perfusion experiments.
Main Results:
- Chlorambucil-bile acid conjugates inhibited taurocholate uptake, indicating interaction with bile acid transporters.
- Conjugates retained bile acid character and demonstrated drug activity (protein alkylation).
- Bile acid conjugates showed enhanced biliary secretion compared to parent drugs.
Conclusions:
- Modified bile acids can function as effective "Trojan horses" for liver-specific drug delivery.
- This approach offers promising pharmacological strategies for developing targeted liver and biliary system therapies.